Serine‐227 in the N‐terminal kinase domain of RSK2 is a potential therapeutic target for mantle cell lymphoma
Yayoi Matsumura‐Kimoto(Kyoto Prefectural University of Medicine), Junya Kuroda(Kyoto Prefectural University of Medicine)
Cited by 10
Related Papers
Apoptosis-based dual molecular targeting by INNO-406, a second-generation Bcr-Abl inhibitor, and ABT-737, an inhibitor of antiapoptotic Bcl-2 proteins, against Bcr-Abl-positive leukemia
|Cell Death and Differentiation|2007|65
p53‐independent anti‐tumor effects of the nitrogen‐containing bisphosphonate zoledronic acid
|Cancer Science|2004|37
BRD4-Regulated Molecular Targets in Mantle Cell Lymphoma: Insights into Targeted Therapeutic Approach
|Cancer Genomics & Proteomics|2019|18
miR‐17‐92 cluster‐BTG2 axis regulates B‐cell receptor signaling in mantle cell lymphoma
|Cancer Science|2023|7